Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 8/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28367268 | 0.82 | FDPS (0.47) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL10242782 | 0.80 | FDPS (0.45) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL27281668 | 0.78 | FDPS (0.35) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL17559999 | 0.78 | FDPS (0.44) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL5483323 | 0.78 | FDPS (0.44) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL27907659 | 0.76 | FDPS (0.42) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL28653083 | 0.76 | FDPS (0.42) | FDPSALDH1A1CA2MAPK1CA1 | |
| Hydrochloric Acid SCHEMBL29015267 | 0.76 | FDPS (0.42) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL11496837 | 0.76 | CA2 (0.42) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL16970187 | 0.75 | FDPS (0.36) | FDPSALDH1A1CA2MAPK1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1841603-A2 | TIRE COMPOSITIONS AND VULCANIZATES THEREOF HAVING IMPROVED SILICA REINFORCEMENT | Bridgestone Corporation (JP) | 2007-10-10 | — | — | EP | claimed |
| WO-2006076670-A2 | TIRE COMPOSITIONS AND VULCANIZATES THEREOF HAVING IMPROVED SILICA REINFORCEMENT | BRIDGESTONE CORPORATION (JP) | 2006-07-20 | — | — | WO | claimed |
| EP-3830163-B1 | COATING COMPOSITION COMPRISING POLYSILOXANE-MODIFIED POLYURETHANE FOR SOFT-FEEL, STAIN RESISTANT COATINGS | AKZO NOBEL COATINGS INT BV (NL) | 2024-02-14 | — | — | EP | disclosed |
| EP-3418354-B1 | FABRIC SOFTENER ACTIVE COMPOSITIONS | KAO CORP SA (ES) | 2020-06-03 | — | — | EP | disclosed |
| EP-3418355-B1 | FABRIC SOFTENER ACTIVE COMPOSITIONS | KAO CORP SA (ES) | 2020-06-03 | — | — | EP | disclosed |
| US-10570354-B2 | Fabric softener active compositions | KAO CORPORATION S.A. (ES) | 2020-02-25 | — | — | US | disclosed |
| EP-2004194-A2 | AZOXYSTROBIN FORMULATIONS | Syngeta Participations AG (CH) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007118001-A2 | AZOXYSTROBIN FORMULATIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2007-10-18 | — | — | WO | disclosed |
| EP-1841603-A2 | TIRE COMPOSITIONS AND VULCANIZATES THEREOF HAVING IMPROVED SILICA REINFORCEMENT | Bridgestone Corporation (JP) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006076670-A2 | TIRE COMPOSITIONS AND VULCANIZATES THEREOF HAVING IMPROVED SILICA REINFORCEMENT | BRIDGESTONE CORPORATION (JP) | 2006-07-20 | — | — | WO | disclosed |
| US-20040220112-A1 | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | ADOLOR CORPORATION | 2004-11-04 | — | — | US | disclosed |
| EP-0590033-A1 | POLYESTER-BASED COATING COMPOSITIONS HAVING HIGH PIGMENT-TO-BINDER RATIOS | EXXON CHEMICAL PATENTS INC. (US) | 1994-04-06 | — | — | EP | disclosed |
| EP-0229367-B1 | 2-CYANOACRYLATE COMPOSITION | Kabushiki Kaisha Alpha Giken (JP) | 1990-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570354-B2 | Fabric softener active compositions | FASN, ELOVL5, ELOVL1 | FDPS 2273/4885ALDH1A1 1064/4885CA2 3733/4885 |
| US-20040220112-A1 | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | OPRK1, OPRD1, OPRM1 | FDPS 4632/4885ALDH1A1 3340/4885CA2 2255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.